About Brainomix
Brainomix is an Oxford University spin-out that has revolutionized medical imaging with AI-powered platforms automating validated imaging biomarkers to improve diagnosis and treatment decisions. The company's flagship product, Brainomix 360 Stroke, is the world's most comprehensive stroke imaging solution, trusted by healthcare systems globally to drive better patient outcomes. The platform includes e-ASPECTS for stroke assessment, e-CTA for large vessel occlusion identification, e-CTP for CT perfusion analysis, e-MRI for advanced imaging, and Triage Stroke/LVO for real-time alerts. Building on its stroke care success, Brainomix has expanded into pulmonary medicine with e-Lung, an FDA-cleared AI platform that automatically identifies and quantifies features on CT lung scans, and is exploring cancer applications with fully automated solutions for solid tumor assessment. The company serves health systems, stroke centers, and clinical research organizations across Europe, the UK, and the United States. Brainomix's technology has been deployed nationwide in Wales and is used in leading hospitals across Germany, Italy, Hungary, Poland, Turkey, and other countries. The company partners with pharmaceutical companies and life sciences organizations to improve clinical trial success and foster broader adoption of therapies in stroke, lung fibrosis, and cancer. Founded by Dr. Michalis Papadakis and built on scientific excellence from Oxford, Brainomix continues to push the boundaries of AI-driven healthcare innovation.
Mission & Story
Mission
We turn ordinary scans into extraordinary insights, enabling precision medicine for better treatment decisions.
Founding Story
Brainomix launched as a spin-out from the University of Oxford, built on a foundation of scientific excellence and commitment to innovation. The company was co-founded by Dr. Michalis Papadakis, who serves as CEO.
Clinical Focus
Medical conditions and clinical areas addressed by Brainomix.
Who It Serves
Milestones & Awards
Recent Milestones
Nationwide deployment across all stroke centers in Wales (2024). Integration at Eskisehir Osmangazi University Hospital, Turkey (2024). Implementation at Mid and South Essex NHS Foundation Trust (2024). Implementation at Podhale Specialist Hospital, Poland (2024). FDA clearance for e-Lung platform. Expansion into cancer imaging applications.
Awards & Recognition
Reddot Award: Design Concept 2025, Top Science Award at AHA Health Tech Competition 2025, Best Established MedTech Company 2025, Life Sciences & Health Tech Company of the Year, HealthTech Company of the Year 2024, Most Transformative HealthTech Company 2024, Life Sciences & HealthTech Company of the Year 2023, Innovative Tech Company, Best Established MedTech Company 2023
Key Partnerships
Company Details
- Headquarters
- Oxford, England, United Kingdom
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.